COLUMBIA CARE LLC has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are BRAEBURN PHARMACEUTICALS INC, BESINS HEALTHCARE and TOLTEC PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks | |
#4 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Enzymes | |
#5 | Tobacco |
# | Name | Total Patents |
---|---|---|
#1 | Dely Aaron | 8 |
#2 | Dely Aaron Michael | 6 |
#3 | Mordas Donald Matthew | 3 |
#4 | Ben-Ari Shaun | 3 |
#5 | Aaron Dely | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020146753A1 | Rapidly disintegrating oral tablet | |
WO2020146383A1 | Inhalable dosage form of cannabinoid extract | |
WO2020142692A1 | Topical formulations having cannabinoid | |
WO2020097358A1 | Suppository formulations having cannabinoid | |
WO2020097362A1 | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof | |
WO2020097187A1 | Stabilized terpine-enriched cannabinoid extract and methods of use thereof | |
CA3092060A1 | Hard-pressed scored splittable marijuana tablets | |
EP3525764A1 | An oral composition of extracted cannabinoids and methods of use thereof |